Teva Comments on Anticipated At-Risk U.S. Launch of Generic Glatiramer Acetate 40mg/mL and Launch of Generic Glatiramer Acetate 20mg/mL

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. ORCL
3. USO
4. LLY
5. KKR
6. DAVA
7. PSKY
8. MONC:IM
9. PTON
10. NYXH

Go back to Teva Comments on Anticipated At-Risk U.S. Launch of Generic Glatiramer Acetate 40mg/mL and Launch of Generic Glatiramer Acetate 20mg/mL
TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 40.06 --0 (-0%)
Previous Close $40.06    52 Week High $66.55 
Open $40.06    52 Week Low $37.82 
Day High $40.06    P/E N/A 
Day Low $40.06    EPS $0.00 
Volume 7,654       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 40.06 --0 (-0%)
Previous Close $40.06    52 Week High $66.55 
Open $40.06    52 Week Low $37.82 
Day High $40.06    P/E N/A 
Day Low $40.06    EPS $0.00 
Volume 7,654